You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 2026 to 2050 of about 5880
Next 25
06/21/2014
Low carb ketogenic diet can manage cancer, says Dr. Adrienne Scheck
NW BIO REAFFIRMS DCVAX(R)-DIRECT CLINICAL TRIAL INTERIM DATA ANNOUNCEMENTS
06/19/2014
Progesterone could become tool versus brain cancer
UC Davis Finding Opens Door to New Therapies for Brain Infections and Cancer
Effect of metformin on the human T98G glioblastoma multiforme cell line.
Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme.
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: Involvement of abnormal cholesterol trafficking.
06/16/2014
ImmunoCellular Therapeutics Presents Updated ICT-107 Phase II Data in Patients with Newly Diagnosed Glioblastoma at the 2014 ASCO Annual Meeting
06/14/2014
MUSELLA FOUNDATION AWARDS 8 BRAIN TUMOR RESEARCH GRANTS
06/13/2014
Novocure Announces the Presentation of Subgroup Survival Data for Recurrent Glioblastoma Patients Treated with NovoTTF™ Therapy
06/11/2014
Ipilimumab plus nivolumab demonstrated encouraging activity in advanced melanoma
06/10/2014
Carbon ion beam is more effective to induce cell death in sphere-type A172 human glioblastoma cells compared with X-rays.
06/08/2014
U.S. to test immunotherapy drugs on newly diagnosed brain tumors
The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTFTM-100A system.
05/28/2014
UAB study identifies new way brain tumors become more malignant
EMA advisors reject Avastin for brain cancer
05/25/2014
The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study.
05/21/2014
Diffusion Pharmaceuticals Clinical Trial of TSC in Brain Cancer Reaches One Year Interim Endpoint
The Electric Anticancer Helmet Battles Brain Tumors
Autologous T cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma.
Musella Foundation Hosts 1.5 Mile Walk at CMC Park
Dr. Al Musella named as Adviser to the Glioblastoma Drug Discovery Group at Duke
Full Power Living Radio: Our Amazing Human Spirit: Coping with Childrens Brain Tumors
05/20/2014
VISUAL REHABILITATION AND THERAPY SEMINAR (NJ)
05/19/2014
Novocure Announces the Publication of New Survival Data for Recurrent Glioblastoma Patients Treated with NovoTTF™ Therapy